Michael Greeley
About Michael Greeley
Michael Greeley is the Clinical Operations Lead at Bristol Myers Squibb, with over 15 years of experience in clinical research and trial management.
Current Role at Bristol Myers Squibb
Michael Greeley currently holds the position of Clinical Operations Lead at Bristol Myers Squibb. In this role, he oversees clinical operations, ensuring that clinical trials are executed efficiently and meet regulatory requirements. His responsibilities include project management, resource allocation, and collaborating with different departments to achieve the company’s clinical research objectives.
Past Experience at Bristol Myers Squibb
Before becoming Clinical Operations Lead at Bristol Myers Squibb, Michael Greeley served as Associate Director, Global Trial Manager, from 2020 to 2021. He also held the position of Senior Global Trial Manager from 2019 to 2020. In these roles, he was responsible for overseeing global clinical trials, managing clinical operations, and ensuring compliance with regulatory standards.
Previous Roles at Celgene and Novartis
Prior to his tenure at Bristol Myers Squibb, Michael Greeley worked at Celgene as a Senior Clinical Trial Manager from 2016 to 2019. He also spent significant time at Novartis, where he served as an Expert Clinical Manager from 2014 to 2016 and as a Clinical Trial Leader from 2011 to 2014 in East Hanover, NJ. His roles involved managing clinical trials, ensuring compliance, and coordinating with cross-functional teams.
Foundational Career at New England Research Institutes and Epix Pharmaceuticals
Michael Greeley began his career at New England Research Institutes, Inc. (NERI), where he worked as an Associate Project Manager from 2010 to 2011 and as a Clinical Research Associate from 2009 to 2010. He then transitioned to Epix Pharmaceuticals, working as a Clinical Research Associate from 2007 to 2009. These early roles provided him with foundational experience in clinical research and trial management.
Educational Background
Michael Greeley holds a Master of Science in Clinical Research Organization and Management from Drexel University, which he completed from 2007 to 2010. He also obtained a Bachelor of Science in Microbiology from Auburn University, completed from 1994 to 1998. His educational background laid the foundation for his extensive career in clinical research and trial management.